» Articles » PMID: 37747480

[ECLS Shock Study-no Advantage for Venoarterial ECMO in Cardiogenic Shock]

Overview
Date 2023 Sep 25
PMID 37747480
Authors
Affiliations
Soon will be listed here.
References
1.
Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi A . Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. N Engl J Med. 2023; 389(14):1286-1297. DOI: 10.1056/NEJMoa2307227. View

2.
Lauridsen M, Rorth R, Lindholm M, Kjaergaard J, Schmidt M, Moller J . Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005 to 2017: A nationwide cohort study. Am Heart J. 2020; 229:127-137. DOI: 10.1016/j.ahj.2020.08.012. View

3.
Jung C, Fuernau G, Eitel I, Desch S, Schuler G, Kelm M . Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol. 2016; 106(5):341-349. DOI: 10.1007/s00392-016-1060-3. View

4.
Bruno R, Wollborn J, Fengler K, Flick M, Wunder C, Allgauer S . Direct assessment of microcirculation in shock: a randomized-controlled multicenter study. Intensive Care Med. 2023; 49(6):645-655. PMC: 10242221. DOI: 10.1007/s00134-023-07098-5. View

5.
Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14):1287-96. DOI: 10.1056/NEJMoa1208410. View